Physician profile
Manjit K Wright
NPI 1891031019
$2,790.75
in general payments reported to CMS, 2019-2025
20 companies · $1,757 in 2025
The $1,757 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $354 · 2022: $57.34 · 2024: $623 · 2025: $1,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,379.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $877.29 | 2024-2025 | |
| Abbott Laboratories | $385.79 | 2021-2025 | Proclaim |
| Ucb, INC. | $352.57 | 2024-2025 | Bimzelx, Cimzia |
| Amgen INC. | $335.82 | 2024-2025 | Krystexxa, Evenity, Otezla |
| Actelion Pharmaceuticals US, INC. | $148.22 | 2024 | Opsumit, Uptravi |
| Pfizer INC. | $118.58 | 2024-2025 | |
| Janssen Biotech, INC. | $97.64 | 2025 | Tremfya |
| Genzyme Corporation | $73.67 | 2024-2025 | |
| Radius Health, INC. | $71.41 | 2024-2025 | Tymlos |
| Mallinckrodt Hospital Products INC. | $56.19 | 2024-2025 | Acthar |
| Organon LLC | $50.81 | 2024-2025 | Nexplanon, Renflexis, Hadlima |
| Lucid Diagnostics INC. | $44.92 | 2021 | |
| Fresenius Kabi USA, LLC | $44.64 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $25.34 | 2025 | Orencia |
| Alexion Pharmaceuticals, INC. | $21.86 | 2025 | Strensiq |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19.67 | 2025 | Actemra |
| Xeris Pharmaceuticals, INC. | $19.02 | 2025 | Keveyis |
| Sobi, INC | $16.33 | 2025 | |
| Kyowa Kirin, INC. | $15.79 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $15.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manjit Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.